Overview
Respiratory conditions caused by vapor exposure often manifest as non-infectious acute inflammation affecting the upper respiratory tract, including pharyngitis, laryngitis, and tonsillitis. Symptoms typically include mucosal congestion, local redness, fever, and sore throat.Diagnosis
Key Diagnostic Criteria: Symptoms of mucosal congestion, local redness, fever, and sore throat 1.
Recommended Tests: No specific diagnostic tests mentioned; clinical assessment is primary 1.
Grading: Not specified in the provided abstracts 1.Management
First-Line Treatments:
- Nimesulide: 200 mg/day for 7 days
- Flurbiprofen: 300 mg/day for 7 days
Adjunctive Treatments: Not specified in the provided abstracts 1.Special Populations
Pregnancy: Not addressed in the provided abstracts 1.
Pediatrics: Not addressed in the provided abstracts 1.
Elderly: Not addressed in the provided abstracts 1.
Comorbidities: Not addressed in the provided abstracts 1.Key Recommendations
Nimesulide and flurbiprofen are equally effective in reducing symptoms of non-infectious acute upper respiratory tract inflammation but nimesulide has fewer side effects (Evidence: Moderate) 1.
Consider nimesulide at a dose of 200 mg/day for 7 days as a first-line treatment option due to better tolerability (Evidence: Moderate) 1.
Flurbiprofen at 300 mg/day for 7 days can be used as an alternative first-line treatment, though with a higher incidence of side effects (Evidence: Moderate) 1.References
1 Cadeddu L, Piragine F, Puxeddu P, Scornavacche V, Sellari Franceschini S. Comparison of nimesulide and flurbiprofen in the treatment of non-infectious acute inflammation of the upper respiratory tract. The Journal of international medical research 1988. link